litlas
Log inCreate account

Christine Mateus

Active 2003–2020

Also published as
Christine Matéus
41
Papers
30,593
Citations
40
h-index
41
i10-index

Citations

Citations per year for Christine Mateus1995: 1 citations1997: 1 citations2000: 1 citations2004: 5 citations2005: 7 citations2006: 2 citations2007: 5 citations2008: 7 citations2009: 7 citations2010: 17 citations2011: 17 citations2012: 42 citations2013: 95 citations2014: 186 citations2015: 539 citations2016: 888 citations2017: 985 citations2018: 924 citations2019: 1,990 citations2020: 2,203 citations2021: 1,844 citations2022: 1,308 citations2023: 875 citations2024: 1,131 citations2025: 517 citations2026: 9 citations1996: no citations, so this year is not shown1998–1999: no citations, so these years are not shown2001–2003: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,590 citing papers, 27.4% of this breakdownChina: 2,447 citing papers, 14.6% of this breakdownFrance: 933 citing papers, 5.5% of this breakdownItaly: 801 citing papers, 4.8% of this breakdownUnited Kingdom: 779 citing papers, 4.6% of this breakdownGermany: 775 citing papers, 4.6% of this breakdownJapan: 633 citing papers, 3.8% of this breakdownAustralia: 616 citing papers, 3.7% of this breakdownCanada: 502 citing papers, 3% of this breakdownNetherlands: 483 citing papers, 2.9% of this breakdownSpain: 416 citing papers, 2.5% of this breakdownSwitzerland: 412 citing papers, 2.4% of this breakdown
0%27.4%Other 20.2%

Institutions

Fields

  • Medicine68.4%
  • Biochemistry, Genetics and Molecular Biology17.1%
  • Immunology and Microbiology10.5%
  • Engineering1.8%
  • Pharmacology, Toxicology and Pharmaceutics0.5%
  • Neuroscience0.5%
  • Other1.2%

Topics

  • Cancer Immunotherapy and Biomarkers21.7%
  • Immunotherapy and Immune Responses8.9%
  • CAR-T cell therapy research7%
  • Immune Cell Function and Interaction4.8%
  • Immune cells in cancer2.6%
  • Melanoma and MAPK Pathways2.6%
  • Other52.4%

Coauthors

All papers

Open in search
  1. PD-1 blockade induces responses by inhibiting adaptive immune resistance

    Authors: Paul C. Tumeh, Christina L. Harview, Jennifer H. Yearley, I. Peter Shintaku, Emma Taylor, Lídia Robert, Bartosz Chmielowski, Marko Spasić, Gina Henry, Voicu Ciobanu, Alisha N. West, Manuel Carmona, Christine Kivork, Elizabeth Seja, Grace Cherry, Antonio Gutiérrez, Tristan Grogan, Christine Mateus, Gorana Tomasic, John A. Glaspy, Ryan Emerson, Harlan Robins, Robert H. Pierce, David Elashoff, Caroline Robert, Antoni Ribas - Nature 2014 cited by 6,699

  2. Pembrolizumab versus Ipilimumab in Advanced Melanoma

    Authors: Caroline Robert, Jacob Schachter, Georgina V. Long, Ana Arance, Jean‐Jacques Grob, Laurent Mortier, Adil Daud, Matteo S. Carlino, Catriona M. McNeil, Michal Lotem, James Larkin, Paul Lorigan, Bart Neyns, Christian U. Blank, Omid Hamid, Christine Mateus, Ronnie Shapira‐Frommer, Michele Kosh, Honghong Zhou, Nageatte Ibrahim, Scot Ebbinghaus, Antoni Ribas - New England Journal of Medicine 2015 cited by 5,847

  3. Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab

    Authors: Nathalie Chaput, Patricia Lepage, Clélia Coutzac, Émilie Soularue, K. Le Roux, C. Monot, L. Boselli, Émilie Routier, Lydie Cassard, Michael Collins, Thibaut Vaysse, Lysiane Marthey, Alexander M.M. Eggermont, Vahé Asvatourian, Émilie Lanoy, Christine Mateus, Caroline Robert, Franck Carbonnel - Annals of Oncology 2017 cited by 1,295

  4. Systemic short chain fatty acids limit antitumor effect of CTLA-4 blockade in hosts with cancer

    Authors: Clélia Coutzac, Jean-Mehdi Jouniaux, Angélo Paci, Julien Schmidt, Domenico Mallardo, Atmane Seck, Vahé Asvatourian, Lydie Cassard, Patrick Saulnier, Ludovic Lacroix, Paul‐Louis Woerther, Aurore Vozy, Marie Naigeon, Laëtitia Nebot-Bral, Mélanie Desbois, Ester Simeone, Christine Mateus, Lisa Boselli, Jonathan Grivel, Émilie Soularue, Patricia Lepage, Franck Carbonnel, Paolo A. Ascierto, Caroline Robert, Nathalie Chaput - Nature Communications 2020 cited by 469

  5. Immune-related adverse events with immune checkpoint blockade: a comprehensive review

    Authors: Jean‐Marie Michot, Camille Bigenwald, Stéphane Champiat, Michael Collins, Franck Carbonnel, Sophie Postel‐Vinay, A. Berdelou, Andreea Varga, Rastislav Bahleda, Antoine Hollebecque, Christophe Massard, Alina Fuerea, Vincent Ribrag, Anas Gazzah, Jean‐Pierre Armand, Nadia Amellal, Eric Angevin, Nicolas Noël, C. Boutros, Christine Mateus, Caroline Robert, Jean‐Charles Soria, Aurélien Marabelle, Olivier Lambotte - European Journal of Cancer 2016 cited by 2,129

  6. Safety profiles of anti-CTLA-4 and anti-PD-1 antibodies alone and in combination

    Authors: C. Boutros, Ahmad A. Tarhini, Émilie Routier, Olivier Lambotte, François Leroy Ladurie, Franck Carbonnel, Hassane Izzeddine, Aurélien Marabelle, Stéphane Champiat, Armandine Berdelou, Émilie Lanoy, Matthieu Texier, C. Libenciuc, Alexander M.M. Eggermont, Jean‐Charles Soria, Christine Mateus, Caroline Robert - Nature Reviews Clinical Oncology 2016 cited by 1,100

  7. Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma

    Authors: Omid Hamid, Caroline Robert, Adil Daud, F. Stephen Hodi, Wen-Jen Hwu, Richard Kefford, Jedd D. Wolchok, Peter Hersey, Richard W. Joseph, Jeffrey S. Weber, Roxana Dronca, Tara C. Gangadhar, Amita Patnaik, Hassane M. Zarour, Anthony M. Joshua, Kevin Gergich, Jeroen Elassaiss‐Schaap, Alain P. Algazi, Christine Mateus, Peter D. Boasberg, Paul C. Tumeh, Bartosz Chmielowski, Scot Ebbinghaus, Xiaoyun Li, Sunyu Kang, Antoni Ribas - New England Journal of Medicine 2013 cited by 3,395

  8. Association of Pembrolizumab With Tumor Response and Survival Among Patients With Advanced Melanoma

    Authors: Antoni Ribas, Omid Hamid, Adil Daud, F. Stephen Hodi, Jedd D. Wolchok, Richard Kefford, Anthony M. Joshua, Amita Patnaik, Wen-Jen Hwu, Jeffrey S. Weber, Tara C. Gangadhar, Peter Hersey, Roxana Dronca, Richard W. Joseph, Hassane M. Zarour, Bartosz Chmielowski, Donald P. Lawrence, Alain P. Algazi, Naiyer A. Rizvi, Brianna Hoffner, Christine Mateus, Kevin Gergich, Jill A. Lindia, Maxine Giannotti, Xiaoyun Li, Scot Ebbinghaus, Soonmo Peter Kang, Caroline Robert - JAMA 2016 cited by 1,062

  9. Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial

    Authors: Caroline Robert, Antoni Ribas, Jedd D. Wolchok, F. Stephen Hodi, Omid Hamid, Richard Kefford, Jeffrey S. Weber, Anthony M. Joshua, Wen-Jen Hwu, Tara C. Gangadhar, Amita Patnaik, Roxana Dronca, Hassane M. Zarour, Richard W. Joseph, Peter D. Boasberg, Bartosz Chmielowski, Christine Mateus, Michael A. Postow, Kevin Gergich, Jeroen Elassaiss‐Schaap, Xiaoyun Li, Robert Iannone, Scot Ebbinghaus, Soonmo Peter Kang, Adil Daud - The Lancet 2014 cited by 1,761

  10. Characterization of liver injury induced by cancer immunotherapy using immune checkpoint inhibitors

    Authors: Eléonora De Martin, Jean‐Marie Michot, Barbara Papouin, Stéphane Champiat, Christine Mateus, Olivier Lambotte, Bruno Roche, Térésa Antonini, Audrey Coilly, Salim Laghouati, Caroline Robert, Aurélien Marabelle, Catherine Guettier, Didier Samuel - Journal of Hepatology 2018 cited by 532

  11. Management of immune checkpoint blockade dysimmune toxicities: a collaborative position paper

    Authors: Stéphane Champiat, Olivier Lambotte, Emmanuel Barreau, Rakiba Belkhir, A. Berdelou, Franck Carbonnel, Cécile Cauquil, P. Chanson, Michael Collins, Antoine Dürrbach, Stéphane Éderhy, S. Feuillet, Arnaud François, Julien Lazarovici, Jérôme Le Pavec, Eléonora De Martin, Christine Mateus, Jean‐Marie Michot, Didier Samuel, Jean‐Charles Soria, Caroline Robert, Alexander M.M. Eggermont, Aurélien Marabelle - Annals of Oncology 2015 cited by 893

  12. Safety and efficacy of anti-programmed death 1 antibodies in patients with cancer and pre-existing autoimmune or inflammatory disease

    Authors: François‐Xavier Danlos, Anne-Laure Voisin, Valérie Dyevre, Jean‐Marie Michot, Émilie Routier, Laurent Taillade, Stéphane Champiat, Sandrine Aspeslagh, Julien Haroche, Laurence Albigès, Christophe Massard, Nicolas Girard, Stéphane Dalle, Benjamin Besse, Salim Laghouati, Jean‐Charles Soria, Christine Mateus, Caroline Robert, Émilie Lanoy, Aurélien Marabelle, Olivier Lambotte - European Journal of Cancer 2018 cited by 311

  13. Association of Vitiligo With Tumor Response in Patients With Metastatic Melanoma Treated With Pembrolizumab

    Authors: Camille Hua, Lise Boussemart, Christine Mateus, Émilie Routier, C. Boutros, H. Cazenave, R. Viollet, Marina Thomas, Séverine Le Roy, Naima Benannoune, Gorana Tomasic, Jean‐Charles Soria, Stéphane Champiat, Matthieu Texier, Émilie Lanoy, Caroline Robert - JAMA Dermatology 2015 cited by 650

  14. Cancer Immunotherapy with Anti-CTLA-4 Monoclonal Antibodies Induces an Inflammatory Bowel Disease

    Authors: Lysiane Marthey, Christine Mateus, Charlotte Mussini, Maria Nachury, Stéphane Nancey, Florent Grange, Camille Zallot, Laurent Peyrin‐Biroulet, Jean‐François Rahier, Mario Beauregard, Laurent Mortier, Clélia Coutzac, Émilie Soularue, Émilie Lanoy, Nathalie Kapel, David Planchard, Nathalie Chaput, Caroline Robert, Franck Carbonnel - Journal of Crohn s and Colitis 2016 cited by 342

  15. Haematological immune-related adverse events induced by anti-PD-1 or anti-PD-L1 immunotherapy: a descriptive observational study

    Authors: Nicolas Delanoy, Jean‐Marie Michot, Thibault Comont, N. Kramkimel, Julien Lazarovici, Romain Dupont, Stéphane Champiat, Claude Chahine, Caroline Robert, Charles Herbaux, Benjamin Besse, Aude Guillemin, Christine Mateus, Patricia Pautier, Philippe Saïag, Emanuela Madonna, Marie Maerevoet, Jean-Christophe Bout, Charlotte Leduc, P. Biscay, Gilles Quéré, Charlée Nardin, Mikaël Ebbo, Laurence Albigès, Grégoire Marret, Virginie Levrat, C. Dujon, Jacques Vargaftig, Salim Laghouati, Laure Croisille, Anne-Laure Voisin, Bertrand Godeau, Christophe Massard, Vincent Ribrag, Aurélien Marabelle, Marc Michel, Olivier Lambotte - The Lancet Haematology 2018 cited by 292

  16. A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma

    Authors: Corine Bertolotto, Fabienne Lesueur, Sandy Giuliano, Thomas Strub, Mahaut de Lichy, Karine Bille, Philippe Dessen, Benoit d’Hayer, Hamida Mohamdi, Audrey Remenieras, E. Maubec, Arnaud de la Fouchardière, Vincent Molinié, P. Vabres, Stéphane Dalle, Nicolas Poulalhon, Tanguy Martin‐Denavit, L. Thomas, Pascale Andry-Benzaquen, N. Dupin, F. Boitier, Annick Rossi, Jean‐Luc Perrot, B. Labeille, Caroline Robert, Bernard Escudier, Olivier Caron, Laurence Brugières, Simon Saule, Betty Gardie, Sophie Gad, Stéphane Richard, Jérôme Couturier, Bin Tean Teh, Paola Ghiorzo, Lorenza Pastorino, Susana Puig, Célia Bádenas, Håkan Olsson, Christian Ingvar, Etienne Rouleau, Rosette Lidereau, Philippe Bahadoran, Philippe Vielh, Eve Corda, Hélène Blanché, Diana Zélénika, Pilar Galán, The French Familial Melanoma Study Group, F. Aubin, Bertrand Bachollet, Céline Becuwe, Pascaline Berthet, Yves Jean Bignon, Valérie Bonadona, Jean‐Louis Bonafé, Marie‐Noëlle Bonnet‐Dupeyron, F. Cambazard, J. Chevrant‐Breton, Isabelle Coupier, S. Dalac, Liliane Demange, M. D’Incan, Catherine Dugast, Laurence Faivre, Lynda Vincent-Fétita, Marion Gauthier-Villars, Brigitte Gilbert, Florent Grange, Jean‐Jacques Grob, Philippe Humbert, Nicolas Janin, Pascal Joly, Delphine Kérob, Christine Lasset, Dominique Leroux, J. Levang, Jean‐Marc Limacher, C. Bulaï Livideanu, Michel Longy, Alain Lortholary, Dominique Stoppa-Lyonnet, Sandrine Mansard, L Mansuy, Karine Marrou, Christine Matéus, Christine Maugard, Nicolás Meyer, Catherine Noguès, P Souteyrand, Laurence Venat‐Bouvet, Hélène Zattara, Valérie Chaudru, Gilbert Lenoir, Mark Lathrop, Irwin Davidson, Marie-Françoise Avril, Florence Démenais, Robert Ballotti, Brigitte Bressac–de Paillerets - Nature 2011 cited by 522

  17. Prevalence of immune-related systemic adverse events in patients treated with anti-Programmed cell Death 1/anti-Programmed cell Death-Ligand 1 agents: A single-centre pharmacovigilance database analysis

    Authors: S. Le Burel, Stéphane Champiat, Christine Mateus, Aurélien Marabelle, Jean‐Marie Michot, Caroline Robert, Rakiba Belkhir, Jean‐Charles Soria, Salim Laghouati, Anne-Laure Voisin, O. Fain, A. Mékinian, Laetitia Coutte, Tali‐Anne Szwebel, Laetitia Dunogeant, Bertrand Lioger, Cécile Luxembourger, Xavier Mariette, Olivier Lambotte - European Journal of Cancer 2017 cited by 199

  18. An epitranscriptomic mechanism underlies selective mRNA translation remodelling in melanoma persister cells

    Authors: Shensi Shen, Sara Faouzi, Amandine Bastide, Sylvain Martineau, Hélène Malka-Mahieu, Yu Fu, Xiaoxiao Sun, Christine Mateus, Émilie Routier, Séverine Le Roy, Laurent Désaubry, Fabrice André, Alexander M.M. Eggermont, Alexandre David, Jean‐Yves Scoazec, Stéphan Vagner, Caroline Robert - Nature Communications 2019 cited by 100

  19. The Price of Tumor Control: An Analysis of Rare Side Effects of Anti-CTLA-4 Therapy in Metastatic Melanoma from the Ipilimumab Network

    Authors: Caroline Voskens, Simone M. Goldinger, Carmen Loquai, Caroline Robert, Katharina C. Kaehler, Carola Berking, Tanja Bergmann, Clemens L. Bockmeyer, Thomas Eigentler, Michael Fluck, Claus Garbe, Ralf Gutzmer, Stephan Grabbe, Axel Hauschild, Rüdiger Hein, Gheorghe Hundorfean, Armin Justich, Ulrich Keller, Christina L. Klein, Christine Mateus, Peter Mohr, Sylvie Paetzold, Imke Satzger, Dirk Schadendorf, Marc Schlaeppi, Gerold Schuler, Beatrice Schuler‐Thurner, Uwe Trefzer, Jens Ulrich, Julia Vaübel, Roger von Moos, Patrik Weder, Tabea Wilhelm, Daniela Göppner, Reinhard Dummer, Lucie Heinzerling - PLoS ONE 2013 cited by 470

  20. Inflammatory gastrointestinal diseases associated with PD-1 blockade antibodies

    Authors: Michael Collins, Jean‐Marie Michot, F.X. Danlos, Charlotte Mussini, Émilie Soularue, Christine Mateus, Delphine Loirat, Anthony Buisson, Isabelle Rosa, Olivier Lambotte, Salim Laghouati, Nathalie Chaput, Clélia Coutzac, Anne-Laure Voisin, Jean‐Charles Soria, Aurélien Marabelle, Stéphane Champiat, Caroline Robert, Franck Carbonnel - Annals of Oncology 2017 cited by 154

  21. The 2016–2019 ImmunoTOX assessment board report of collaborative management of immune-related adverse events, an observational clinical study

    Authors: Jean‐Marie Michot, Ariane Lappara, Jérôme Le Pavec, Audrey Simonaggio, Michael Collins, Eléonora De Martin, François‐Xavier Danlos, Samy Ammari, Cécile Cauquil, Stéphane Éderhy, Emmanuel Barreau, Rakiba Belkhir, A. Berdelou, Julien Lazarovici, Philippe Chanson, Hassan Izzedine, Andrei Seferian, Christine Le Pajolec, Capucine Baldini, Patricia Martín-Romano, Xavier Mariette, Caroline Robert, Benjamin Besse, Antoine Hollebecque, Andréa Varga, Salim Laghouati, Christine Mateus, Anne-Laure Voisin, Jean‐Charles Soria, Christophe Massard, Aurélien Marabelle, Stéphane Champiat, Olivier Lambotte - European Journal of Cancer 2020 cited by 59

  22. Anticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25

    Authors: Dalil Hannani, Marie Vétizou, David Enot, Sylvie Rusakiewicz, Nathalie Chaput, David Klatzmann, Mélanie Desbois, Nicolas Jacquelot, Nadège Vimond, Salem Chouaı̈b, Christine Mateus, James P. Allison, Antoni Ribas, Jedd D. Wolchok, Jianda Yuan, Phillip Wong, Michael A. Postow, Andrzej Maćkiewicz, Jacek Mackiewicz, Dirk Schadendorff, Dirk Jaeger, Alan J. Korman, Keith S. Bahjat, Michele Maio, Luana Calabrò, Michele W.L. Teng, Mark J. Smyth, Alexander M.M. Eggermont, Caroline Robert, Guido Kroemer, Laurence Zitvogel - Cell Research 2015 cited by 160

  23. Prevalence and Clinical Patterns of Ocular Complications Associated With Anti-PD-1/PD-L1 Anticancer Immunotherapy

    Authors: Karen Bitton, Jean‐Marie Michot, Emmanuel Barreau, Olivier Lambotte, Oscar Haigh, Aurélien Marabelle, Anne-Laure Voisin, Christine Mateus, Anne-Laure Rémond, C. Couret, Stéphane Champiat, Marc Labétoulle, Antoine Rousseau - American Journal of Ophthalmology 2019 cited by 88

  24. Colon Immune-Related Adverse Events: Anti-CTLA-4 and Anti-PD-1 Blockade Induce Distinct Immunopathological Entities

    Authors: Clélia Coutzac, Julien Adam, Émilie Soularue, Michael Collins, Antoine Racine, Charlotte Mussini, Lisa Boselli, Nyam Kamsu-Kom, Christine Mateus, Mélinda Charrier, Lydie Cassard, David Planchard, Vincent Ribrag, Karim Fizazi, Yohann Loriot, Patricia Lepage, Jean‐Yves Scoazec, Caroline Robert, Franck Carbonnel, Nathalie Chaput - Journal of Crohn s and Colitis 2017 cited by 166